Search

solution structures of BRD4 second bromodomain with NF-kB-K310ac peptide
Authors
Zhang, G., Liu, R., Zhong, Y., Plotnikov, A.N., Zhang, W., Rusinova, E., Gerona-Nevarro, G., Moshkina, N., Joshua, J., Chuang, P.Y., Ohlmeyer, M., He, J.
Assembly
BRD4 second bromodomain with NF-kB-K310ac peptide
Entity
1. BRD4 second bromodomain with NF-kB-K310ac peptide, entity 1 (polymer, Thiol state: not present), 13 monomers, 1660.931 Da Detail

RTYETFXSIM KKS


2. BRD4 second bromodomain with NF-kB-K310ac peptide, entity 2 (polymer), 128 monomers, 14817.86 Da Detail

KDVPDSQQHP APEKSSKVSE QLKCCSGILK EMFAKKHAAY AWPFYKPVDV EALGLHDYCD IIKHPMDMST IKSKLEAREY RDAQEFGADV RLMFSNCYKY NPPDHEVVAM ARKLQDVFEM RFAKMPDE


Total weight
16478.791 Da
Max. entity weight
14817.86 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Refine. method
DGSA-distance geometry simulated annealing, torsion angle dynamics
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 98.6 %, Completeness: 79.7 %, Completeness (bb): 80.2 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All79.7 % (1347 of 1690)84.7 % (755 of 891)71.5 % (472 of 660)86.3 % (120 of 139)
Backbone80.2 % (659 of 822)94.5 % (259 of 274)67.9 % (283 of 417)89.3 % (117 of 131)
Sidechain80.9 % (813 of 1005)80.4 % (496 of 617)82.6 % (314 of 380)37.5 % (3 of 8)
Aromatic59.5 % (94 of 158)63.3 % (50 of 79)55.1 % (43 of 78)100.0 % (1 of 1)
Methyl95.5 % (105 of 110)98.2 % (54 of 55)92.7 % (51 of 55)

1. entity 1

RTYETFXSIM KKS

2. entity 2

KDVPDSQQHP APEKSSKVSE QLKCCSGILK EMFAKKHAAY AWPFYKPVDV EALGLHDYCD IIKHPMDMST IKSKLEAREY RDAQEFGADV RLMFSNCYKY NPPDHEVVAM ARKLQDVFEM RFAKMPDE

Sample #1

Solvent system 100% D2O, Pressure 1 atm, Temperature 298 K, pH 6.5


#NameIsotope labelingTypeConcentration
1sodium phosphatenatural abundance100 mM
2DTT[U-100% 2H]5 mM
3D2Onatural abundance100 %
Sample #2

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 298 K, pH 6.5


#NameIsotope labelingTypeConcentration
4sodium phosphatenatural abundance100 mM
5DTT[U-100% 2H]5 mM
6D2Onatural abundance10 %
7H2Onatural abundance90 %

LACS Plot; CA
Referencing offset: -0.02 ppm, Outliers: 1 Detail
LACS Plot; CB
Referencing offset: -0.02 ppm, Outliers: 1 Detail
LACS Plot; HA
Referencing offset: 0.08 ppm, Outliers: 1 Detail
Protein Blocks Logo
Calculated from 20 models in PDB: 2LSP, Strand ID: A, B Detail


Release date
2012-06-04
Citation
Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition
Zhang, G., Liu, R., Zhong, Y., Plotnikov, A.N., Zhang, W., Zeng, L., Rusinova, E., Gerona-Nevarro, G., Moshkina, N., Joshua, J., Chuang, P.Y., Ohlmeyer, M., He, J., Zhou, M.
J. Biol. Chem. (2012), 287, 28840-28851, PubMed 22645123 , DOI 10.1074/jbc.M112.359505 ,
Related entities 1. BRD4 second bromodomain with NF-kB-K310ac peptide, entity 1, : 1 : 10 entities Detail
Related entities 2. BRD4 second bromodomain with NF-kB-K310ac peptide, entity 2, : 1 : 92 entities Detail
Interaction partners 1. BRD4 second bromodomain with NF-kB-K310ac peptide, entity 1, : 214 interactors Detail
Experiments performed 6 experiments Detail
nullKeywords BRD4, HIV, NF-kB, bromodomain, kidney disease